SkinLabs

    Skin intelligence, locally grounded

    The Daily Skinny Skin Microbiome

    Beiersdorf Just Bet Big on Your Skin's Microbiome — Here's What That Means

    2 September 2026 10 min read 362 views 0
    Close-up texture of a white cosmetic cream smeared on a beige surface
    Photo by Kelsey Curtis on Unsplash

    Eucerin's new DERMOPURE CLINICAL PROBIOM8 line uses dormant skin-native bacteria to treat acne-prone skin, rather than sterilising it.

    Key takeaways

    • Beiersdorf launched Eucerin DERMOPURE CLINICAL PROBIOM8 on 1 September 2026, built around a patented active called TopiC.A.
    • The line uses two viable, dormant strains of skin-native bacteria that activate on skin to support a balanced microbiome.
    • Beiersdorf's microbiome research dates back to the 1990s, with over 120 proprietary studies conducted since 2014.
    • The global acne-prone skin market reached an estimated 4.6 billion euros in 2025, with prevalence highest among 16 to 24-year-olds.
    • South Africa's UV exposure, humidity swings and hard water all add extra stress to the skin barrier and microbiome.

    Sign in to read this briefing

    Free accounts get 3 full briefings every week, no card required. Members get unlimited daily briefings.

    See membership plans

    Comments (0)

    Sign in to join the conversation.